Skip to main content
Erschienen in: World Journal of Surgery 1/2017

29.07.2016 | Original Scientific Report

Surgical Indications of Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Body/Tail Cancer

verfasst von: Teiichi Sugiura, Yukiyasu Okamura, Takaaki Ito, Yusuke Yamamoto, Katsuhiko Uesaka

Erschienen in: World Journal of Surgery | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

The survival impact of distal pancreatectomy (DP) with celiac axis resection for locally advanced pancreatic body/tail cancer remains unclear.

Methods

A total of 16 patients underwent DP with celiac axis resection, while 76 underwent standard DP for pancreatic body/tail cancer. The indications for DP with celiac axis resection included: (a) tumor invasion of either the celiac axis or common hepatic artery or both [CA/CHA (+)] and (b) tumor invasion of the root of the splenic artery, which is difficult to dissect without securing an adequate surgical margin [CA/CHA (−)].

Results

DP with celiac axis resection presented longer operative time and greater amount of blood loss than DP. The median survival time was 17.5 months in the DP with celiac axis resection group and 43.1 months in the DP group (p = 0.040). Among the patients who underwent DP with celiac axis resection, the median survival time was 35.1 months in the CA/CHA (−) group and 13.2 months in the CA/CHA (+) group (p = 0.001). Comparing the patients undergoing standard DP and DP with celiac axis resection with a CA/CHA (−) status, there were no significant differences in either disease-free or overall survival times. The CA19-9 value, CA/CHA (+) status, and microscopic venous infiltration were revealed independent significant prognostic factors.

Conclusions

DP with celiac axis resection should therefore be indicated in patients with a CA/CHA (−) status. However, it is difficult to justify the use of DP with celiac axis resection in patients with CA/CHA (+) status due to the poor survival.
Literatur
1.
Zurück zum Zitat Alexakis N, Halloran C, Raraty M et al (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91:1410–1427CrossRefPubMed Alexakis N, Halloran C, Raraty M et al (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91:1410–1427CrossRefPubMed
2.
Zurück zum Zitat Appleby LH (1953) The coeliac axis in the expansion of the operation for gastric carcinoma. Cancer 6:704–707CrossRefPubMed Appleby LH (1953) The coeliac axis in the expansion of the operation for gastric carcinoma. Cancer 6:704–707CrossRefPubMed
3.
Zurück zum Zitat Nimura Y, Hattori T, Miura K et al (1976) Experience of Appleby’s operation for advanced carcinoma of the pancreatic body and tail (in Japanese). Shujutu 30:885–889 Nimura Y, Hattori T, Miura K et al (1976) Experience of Appleby’s operation for advanced carcinoma of the pancreatic body and tail (in Japanese). Shujutu 30:885–889
4.
Zurück zum Zitat Hirano S, Kondo S, Hara T et al (2007) Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg 246:46–51CrossRefPubMedPubMedCentral Hirano S, Kondo S, Hara T et al (2007) Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg 246:46–51CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Wu X, Tao R, Lei R et al (2010) Distal pancreatectomy combined with celiac axis resection in treatment of carcinoma of the body/tail of the pancreas: a single-center experience. Ann Surg Oncol 17:1359–1366CrossRefPubMed Wu X, Tao R, Lei R et al (2010) Distal pancreatectomy combined with celiac axis resection in treatment of carcinoma of the body/tail of the pancreas: a single-center experience. Ann Surg Oncol 17:1359–1366CrossRefPubMed
6.
Zurück zum Zitat Takahashi Y, Kaneoka Y, Maeda A et al (2011) Distal pancreatectomy with celiac axis resection for carcinoma of the body and tail of the pancreas. World J Surg 35:2535–2542CrossRefPubMed Takahashi Y, Kaneoka Y, Maeda A et al (2011) Distal pancreatectomy with celiac axis resection for carcinoma of the body and tail of the pancreas. World J Surg 35:2535–2542CrossRefPubMed
7.
Zurück zum Zitat Yamamoto Y, Sakamoto Y, Ban D et al (2012) Is celiac axis resection justified for T4 pancreatic body cancer? Surgery 151:61–69CrossRefPubMed Yamamoto Y, Sakamoto Y, Ban D et al (2012) Is celiac axis resection justified for T4 pancreatic body cancer? Surgery 151:61–69CrossRefPubMed
8.
Zurück zum Zitat Baumgartner JM, Krasinskas A, Daouadi M et al (2012) Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic adenocarcinoma following neoadjuvant therapy. J Gastrointest Surg 16:1152–1159CrossRefPubMed Baumgartner JM, Krasinskas A, Daouadi M et al (2012) Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic adenocarcinoma following neoadjuvant therapy. J Gastrointest Surg 16:1152–1159CrossRefPubMed
9.
Zurück zum Zitat Okada K, Kawai M, Tani M et al (2013) Surgical strategy for patients with pancreatic body/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection? Surgery 153:365–372CrossRefPubMed Okada K, Kawai M, Tani M et al (2013) Surgical strategy for patients with pancreatic body/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection? Surgery 153:365–372CrossRefPubMed
10.
Zurück zum Zitat Jing W, Zhu G, Hu X et al (2013) Distal pancreatectomy with en bloc celiac axis resection for the treatment of locally advanced pancreatic body and tail cancer. Hepatogastroenterology 60:187–190PubMed Jing W, Zhu G, Hu X et al (2013) Distal pancreatectomy with en bloc celiac axis resection for the treatment of locally advanced pancreatic body and tail cancer. Hepatogastroenterology 60:187–190PubMed
11.
Zurück zum Zitat Cesaretti M, Abdel-Rehim M, Barbier L et al (2016) Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: a major procedure for selected patients. J Visc Surg 153:173–181CrossRefPubMed Cesaretti M, Abdel-Rehim M, Barbier L et al (2016) Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: a major procedure for selected patients. J Visc Surg 153:173–181CrossRefPubMed
12.
Zurück zum Zitat Tsuchikawa T, Hirano S, Nakamura T et al (2015) Detailed analysis of extra-pancreatic nerve plexus invasion in pancreatic body carcinoma analyzed by 50 consecutive series of distal pancreatectomy with en-bloc celiac axis resection. Hepatogastroenterology 62:455–458PubMed Tsuchikawa T, Hirano S, Nakamura T et al (2015) Detailed analysis of extra-pancreatic nerve plexus invasion in pancreatic body carcinoma analyzed by 50 consecutive series of distal pancreatectomy with en-bloc celiac axis resection. Hepatogastroenterology 62:455–458PubMed
13.
14.
Zurück zum Zitat Latona JA, Lamb KM, Pucci MJ et al (2016) Modified Appleby procedure with arterial reconstruction for locally advanced pancreatic adenocarcinoma: a literature review and report of three unusual cases. J Gastrointest Surg 20:300–306CrossRefPubMed Latona JA, Lamb KM, Pucci MJ et al (2016) Modified Appleby procedure with arterial reconstruction for locally advanced pancreatic adenocarcinoma: a literature review and report of three unusual cases. J Gastrointest Surg 20:300–306CrossRefPubMed
15.
Zurück zum Zitat Mittal A, de Reuver PR, Shanbhag S et al (2015) Distal pancreatectomy, splenectomy, and celiac axis resection (DPS-CAR): common hepatic arterial stump pressure should determine the need for arterial reconstruction. Surgery 157:811–817CrossRefPubMed Mittal A, de Reuver PR, Shanbhag S et al (2015) Distal pancreatectomy, splenectomy, and celiac axis resection (DPS-CAR): common hepatic arterial stump pressure should determine the need for arterial reconstruction. Surgery 157:811–817CrossRefPubMed
16.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Witterkind C (2009) TNM classification of malignant tumors. Wiley, New York Sobin LH, Gospodarowicz MK, Witterkind C (2009) TNM classification of malignant tumors. Wiley, New York
17.
Zurück zum Zitat Sugiura T, Uesaka K, Mihara K et al (2013) Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer. Surgery 154:1078–1086CrossRefPubMed Sugiura T, Uesaka K, Mihara K et al (2013) Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer. Surgery 154:1078–1086CrossRefPubMed
18.
Zurück zum Zitat Butturini G, Stocken DD, Wente MN et al (2008) Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg 143:75–83 (discussion 83) CrossRefPubMed Butturini G, Stocken DD, Wente MN et al (2008) Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg 143:75–83 (discussion 83) CrossRefPubMed
19.
Zurück zum Zitat Raut CP, Tseng JF, Sun CC et al (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246:52–60CrossRefPubMedPubMedCentral Raut CP, Tseng JF, Sun CC et al (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246:52–60CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Fatima J, Schnelldorfer T, Barton J et al (2010) Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. Arch Surg 145:167–172CrossRefPubMed Fatima J, Schnelldorfer T, Barton J et al (2010) Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. Arch Surg 145:167–172CrossRefPubMed
21.
Zurück zum Zitat Neoptolemos JP, Stocken DD, Dunn JA et al (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768CrossRefPubMedPubMedCentral Neoptolemos JP, Stocken DD, Dunn JA et al (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Yekebas EF, Bogoevski D, Cataldegirmen G et al (2008) En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 247:300–309CrossRefPubMed Yekebas EF, Bogoevski D, Cataldegirmen G et al (2008) En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 247:300–309CrossRefPubMed
23.
Zurück zum Zitat Howard TJ, Krug JE, Yu J et al (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 10:1338–1345 (discussion 1345–1336) CrossRefPubMed Howard TJ, Krug JE, Yu J et al (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 10:1338–1345 (discussion 1345–1336) CrossRefPubMed
24.
Zurück zum Zitat Ueno H, Ioka T, Ikeda M et al (2013) Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. J Clin Oncol 31:1640–1648CrossRefPubMed Ueno H, Ioka T, Ikeda M et al (2013) Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. J Clin Oncol 31:1640–1648CrossRefPubMed
25.
Zurück zum Zitat Mukherjee S, Hurt CN, Bridgewater J et al (2013) Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. Lancet Oncol 14:317–326CrossRefPubMedPubMedCentral Mukherjee S, Hurt CN, Bridgewater J et al (2013) Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. Lancet Oncol 14:317–326CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Nagakawa T, Mori K, Nakano T et al (1993) Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg 80:619–621CrossRefPubMed Nagakawa T, Mori K, Nakano T et al (1993) Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg 80:619–621CrossRefPubMed
27.
Zurück zum Zitat Kayahara M, Nagakawa T, Konishi I et al (1991) Clinicopathological study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus. Int J Pancreatol 10:105–111PubMed Kayahara M, Nagakawa T, Konishi I et al (1991) Clinicopathological study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus. Int J Pancreatol 10:105–111PubMed
28.
Zurück zum Zitat Katz MH, Pisters PW, Evans DB et al (2008) Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206:833–846 (discussion 846–838) CrossRefPubMed Katz MH, Pisters PW, Evans DB et al (2008) Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206:833–846 (discussion 846–838) CrossRefPubMed
29.
Zurück zum Zitat Barugola G, Partelli S, Crippa S et al (2012) Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. Am J Surg 203:132–139CrossRefPubMed Barugola G, Partelli S, Crippa S et al (2012) Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. Am J Surg 203:132–139CrossRefPubMed
Metadaten
Titel
Surgical Indications of Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Body/Tail Cancer
verfasst von
Teiichi Sugiura
Yukiyasu Okamura
Takaaki Ito
Yusuke Yamamoto
Katsuhiko Uesaka
Publikationsdatum
29.07.2016
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 1/2017
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-016-3670-3

Weitere Artikel der Ausgabe 1/2017

World Journal of Surgery 1/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.